ProForma 2.0
validated simple linear
KLLLLKLLLLKLLLLKLLLLK
Record tools
Copy identifiers or export this single peptide record for a local research note.
Sinapultide
65
Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness.
2
Source DBs
4
Activities
4
Source refs
1
Literature
0
Patents
Integrated record
Length
Molecular weight
Formula
Structure type
Synthesis
Chirality
Family
Gene
Residue composition
Physicochemical profile
Membrane affinity proxy
Solubility proxy
Net charge proxy +5
Binding interaction proxy
Versioned scientific descriptors
Legacy compatibility fields are materialized from the versioned PepDiana computed release; no separate source-reported property is available.
Molecular weight
2469.3984 Da
Molecular formula
C126H238N26O22
Theoretical pI
10.6025
Net charge at pH 7
4.7551
GRAVY
1.9667
Instability index
-22.819
Aromaticity
0
Topological polar surface area
775.42 Ų
cLogP
6.4769
Hydrogen-bond donors
27
Hydrogen-bond acceptors
27
Rotatable bonds
93
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
KLLLLKLLLLKLLLLKLLLLK
HELM 2.0
validated simple linear
PEPTIDE1{K.L.L.L.L.K.L.L.L.L.K.L.L.L.L.K.L.L.L.L.K}$$$$V2.0
Canonical SMILES
validated
CC(C)CC(NC(=O)C(N)CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O
Isomeric SMILES
validated
CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
Follow-up research
Links open third-party resources with the current PepDiana sequence, record name, or chemistry notation as the initial query.
Research workflow
@misc{PEPDIA-INT-017934,
title = {Sinapultide},
author = {{PepDiana Consortium}},
year = {2026},
howpublished = {PepDiana Multifunctional Peptide Database},
url = {http://127.0.0.1:3004/peptides/PEPDIA-INT-017934},
note = {Accessed from local PepDiana development build}
}Sinapultide. (2026). PepDiana record PEPDIA-INT-017934. PepDiana Multifunctional Peptide Database. http://127.0.0.1:3004/peptides/PEPDIA-INT-017934
Integrated source-database annotations
| Stable record | Activity | Subtype | Value | Target | Assay method | Source |
|---|---|---|---|---|---|---|
| CTPDB_P017934_ACT_peptherdia_0000 | Clinical / Approved Drug | General Therapeutic | Not available in the current structured import | Unknown | Not reported by source | 10peptherdia / linked |
| CTPDB_P017934_ACT_thpdb_0001 | Clinical / Approved Drug | General Therapeutic | Not available in the current structured import | Unknown | Not reported by source | Th1146_10669_rec0thpdb / unavailable |
| CTPDB_P017934_ACT_thpdb_0002 | Clinical / Approved Drug | General Therapeutic | Not available in the current structured import | Unknown | Not reported by source | Th1146_10670_rec1thpdb / unavailable |
| CTPDB_P017934_ACT_thpdb_0003 | Clinical / Approved Drug | General Therapeutic | Not available in the current structured import | Unknown | Not reported by source | Th1146_10671_rec2thpdb / unavailable |
Provenance
Citation trail
[{"text": "drugbank.com", "url": "https://go.drugbank.com/drugs/DB11332", "markdown": "[drugbank.com](https://go.drugbank.com/drugs/DB11332)"}, {"text": "fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf", "markdown": "[fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf)"}, {"text": "ncats.io", "url": "https://drugs.ncats.io/drug/040X3AX99T", "markdown": "[ncats.io](https://drugs.ncats.io/drug/040X3AX99T)"}]
Audit surface
Integrated record last updated: 2026-04-15T00:59:21.345173+00:00
Modification summary
No structured modification annotations are available for this record.
{
"toxicity": [
{
"source_db": "thpdb",
"assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
"toxicity_type": "Toxicity"
},
{
"source_db": "thpdb",
"assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
"toxicity_type": "Toxicity"
},
{
"source_db": "thpdb",
"assay_method": "Most common adverse reactions associated with the use of lucinactant are endotracheal tube reflux, pallor, endotracheal tube obstruction, and need for dose interruption.",
"toxicity_type": "Toxicity"
}
]
}[
{
"source_db": "peptherdia",
"organism_name": "Unknown"
},
{
"source_db": "thpdb",
"organism_name": "Unknown"
}
][
{
"status": "Therapeutic",
"drug_name": "Sinapultide",
"source_db": "peptherdia",
"indication": "Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.",
"approval_year": 2012,
"approval_agency": "FDA",
"administration_route": "IT"
}
]{
"status": "Therapeutic",
"drug_name": "Sinapultide",
"source_db": "peptherdia",
"indication": "Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.",
"approval_year": 2012,
"approval_agency": "FDA",
"administration_route": "IT"
}